Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation. [electronic resource]
Producer: 20060927Description: 600-3 p. digitalISSN:- 1445-5994
- Adult
- Bone Density -- drug effects
- Bone Density Conservation Agents -- therapeutic use
- Bone Resorption -- epidemiology
- Diphosphonates -- therapeutic use
- Female
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Imidazoles -- therapeutic use
- Male
- Middle Aged
- Prospective Studies
- Transplantation, Homologous
- Zoledronic Acid
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.